Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant IP FUDR + Chemoradiation in Gastric Cancer
NCT00183911Phase 2Completed
- Sponsor
- University of Southern California
- Start
- Nov 2003
- Primary completion
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of floxuridine in gastric adenocarcinoma, sponsored by University of Southern California. Primary endpoint: Side Effects. Started Nov 2003; status: completed.
02
Drugs
floxuridine
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on NCT00183911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00183911.